Science Tease: CO2 Clears—Or Causes?

Woman undergoing brain scan with doctor monitoring results

Scientists say brief blasts of high-dose carbon dioxide can flush Alzheimer’s-linked proteins from the brain — but other research warns the same gas might help cause the disease.

Story Snapshot

New human studies show that short, high-dose carbon dioxide breathing sessions push Alzheimer’s-related proteins from the brain into the blood.
Researchers claim this works by boosting the brain’s waste-removal “glymphatic” system, which usually activates during deep sleep.
Other peer‑reviewed work links long‑term high carbon dioxide levels to more Alzheimer’s cases and worse brain health.
Experts warn there is still no proven treatment for Alzheimer’s based on carbon dioxide, and unsafe use could be dangerous.

What the new carbon dioxide studies actually found

Researchers in the United States and Europe tested a simple idea: can brief, controlled breathing of air with extra carbon dioxide help the brain push out toxic proteins that build up in Alzheimer’s disease? In one study, older adults and people with Parkinson’s disease breathed air containing about five percent carbon dioxide in short ON-OFF cycles for thirty minutes. After the session, blood tests showed higher levels of amyloid beta and phosphorylated tau, proteins tied to Alzheimer’s, along with other brain-derived proteins.

Scientists interpret these spikes in blood proteins as a sign that waste was moved from the brain into the bloodstream. Imaging during these sessions showed stronger, more rhythmic waves of cerebrospinal fluid, the clear liquid that bathes the brain. This pattern matches the “glymphatic” system, a network that clears out waste during deep sleep. A report on the work described intermittent high carbon dioxide as a way to mimic deep sleep’s pumping action without drugs or surgery. Early media coverage has highlighted the method as non-invasive and based on a gas we all breathe every day.

Why some experts say this might help Alzheimer’s

The hopeful story here focuses on blood flow and fluid movement, not on magic cures. When carbon dioxide in the blood rises briefly, brain blood vessels widen and start to pulse. That pulsing, called vasomotion, can push cerebrospinal fluid through spaces around blood vessels, helping carry away proteins like amyloid beta and tau that are linked to Alzheimer’s and other brain diseases. The Nature study’s authors argue that if this pulsing is repeated over time, it might slow the build-up of toxic proteins and act as a disease-modifying treatment.

Animal work adds another layer of support. In mouse models with Alzheimer’s-like protein problems, daily exposure to air with four and a half to five percent carbon dioxide for several months increased brain blood flow and appeared to improve clearance of amyloid beta and tau. Separate reviews on “medical gases” note that controlled changes in gases such as oxygen, carbon dioxide, and carbon monoxide can trigger protective pathways in the brain and reduce inflammation. Together, this has fueled interest in gas-based therapies as a cheaper, less invasive alternative to expensive drugs and high-tech devices.

Serious warnings: when carbon dioxide stops helping and starts hurting

The same gas that looks helpful in short bursts may be harmful when levels stay high for too long. A study in the International Clinical and Medical Case Reports Journal found a direct link between higher arterial carbon dioxide and more Alzheimer’s cases. The authors describe several ways chronic high carbon dioxide could damage the brain: disrupted blood flow and oxygen delivery, brain acidosis that changes enzyme activity, and activation of inflammatory pathways that promote amyloid build-up and tau changes.

Animal experiments with chronic hypercapnia — long-lasting high carbon dioxide — showed more amyloid precursor protein, greater amyloid beta accumulation, and increased tau phosphorylation, all hallmarks of Alzheimer’s pathology. Other research reports that in people who already have Alzheimer’s, brain blood vessels respond poorly to carbon dioxide. That means the very mechanism these new studies hope to use, carbon dioxide-driven vessel pulsing, may be blunted in the patients who need help the most. A separate abstract even found that at two percent carbon dioxide, glymphatic clearance slowed, raising hard questions about which doses help and which harm.

Safety, hype, and the gap between early data and real treatment

Independent experts are urging caution, especially as social media and some news sites push carbon dioxide breathing as a quick brain “detox.” An investigation by fact‑checkers quoted specialists saying there is no proven benefit to consumer carbon dioxide rebreathing devices and warning of likely harms such as dizziness, fainting, and worse outcomes in people with lung disease. The Food and Drug Administration has also warned families to watch out for “false promises” and “scientific breakthrough” claims around unapproved Alzheimer’s cures, a category that would include do‑it‑yourself gas therapies.

Even in carefully monitored lab settings, researchers stress that altering carbon dioxide is not trivial. High levels can cause headaches, confusion, and loss of consciousness, and people with heart or lung problems face extra risk. The current intermittent hypercapnia protocols use built‑in safety features, like giving plain room air every thirty to thirty‑five seconds and limiting concentrations to around five percent. Still, these studies involve small groups of volunteers and short‑term measurements. There is no long‑term data yet showing that repeated carbon dioxide sessions lower brain amyloid or tau on scans or improve memory and daily function in people with Alzheimer’s.

What this means for patients and families right now

For families watching Alzheimer’s steal their loved ones’ memories while Washington fights and lobbyists get rich, the idea of a cheap gas that might clear the brain is deeply appealing. The early science does show that brief, high‑dose carbon dioxide pulses can push Alzheimer’s-related proteins from the brain into the blood and boost fluid waves that are tied to waste clearance. At the same time, strong evidence links long‑term high carbon dioxide to worse brain health and more Alzheimer’s, not less.

This tension reflects a larger pattern in modern medicine: simple, non‑invasive tricks often look exciting in early trials but many fail when tested in real patients over years. Until larger, longer studies in people with Alzheimer’s show clear benefits and acceptable risks, carbon dioxide therapy belongs in research labs, not in home devices or miracle ads. Patients and caregivers have every right to feel angry that true breakthroughs move slowly while hype moves fast. But the safest step today is to follow proven advice from trusted doctors and to treat gas-based “detox” claims with the same healthy skepticism many Americans already feel toward a system that too often serves elites first and patients last.